Home COVID 19 NATHEALTH In Collaboration With TiE Mumbai Launches ‘Reimagining Healthcare: Industry-Startup Interface Series
COVID 19Latest NewsLet’s Talk HealthSpotlight

NATHEALTH In Collaboration With TiE Mumbai Launches ‘Reimagining Healthcare: Industry-Startup Interface Series

Share
Share

With an aim to strengthen co-innovation between healthcare startups and industry members and accelerate the process of establishing an accessible and technologically advanced healthcare infrastructure, NATHEALTH-Healthcare Federation of India, in collaboration with TiE Mumbai, with IQVIA as knowledge partners and Healthwire as digital media partners, has launched its initiative ‘Reimagining Healthcare: Industry-Startup Interface Series’. The initiative was announced through a webinar on 6th August 2021 and is set to serve as an effective and credible interface that facilitates meaningful partnerships between the healthcare industry and the startup community.

Speaking about the initiative, Dr. Harsh Mahajan, President, NATHEALTH said, “It is the need of the hour to innovate in the healthcare system in India especially in the post-COVID era. Less capacity of testing, inadequacy in skilled healthcare workforce, infrastructural insufficiency and inefficient management is some of the gaps that exist in the Indian healthcare ecosystem. As we prioritise the accessible and affordable healthcare ecosystem in India, the conversation needs to be driven towards expanding India’s health infrastructure by harnessing technologies and innovations through an active and meaningful collaboration between the start-up community and industry. NATHEALTH with its industry connect eco system focus can really lead to development and success of pathbreaking innovation in the healthcare sector of India and will ensure birth of many more unicorns. Covid-19 pandemic may have sparked off innovation, but the key is to sustain this entrepreneurial mindset, in the long run, to address the existing challenges through meaningful collaboration between the startup community and the industry.”

According to Mr. Amit Mookim, Managing Director, IQVIA, South Asia and President, TiE Mumbai “The onset of Coronavirus has fueled the digitization in every sphere. In order to overcome multitude of healthcare challenges, augmenting health infra and digital health are the key focus areas. There is immense opportunity to re-imagine this sector with disruptive technologies such as artificial intelligence, internet of things, healthcare aggregators that are key to improving access to quality care. There is a need to develop citizen centric and consent based digitized health data and maintaining transparency of information is crucial to ensure better patient outcome. NATHEALTH has partnered with TiE Mumbai which empowers startups with knowledge and expertise to adapt to the fast-changing needs of the post-COVID era to increase access and efficiency of healthcare delivery.”

The Renal Project working in the area of dialysis management; V Engage working in the area of teleconsultation and telemonitoring; Meradoc working in the area of telemedicine access; CanceRX providing clinical support for oncology and Bynocs which provides a software to accurately diagnose binocular vision anomalies and works for related therapies – were the few start-ups that participated in the event and shared successful collaborative model with the industry that have been implemented so far. These startups highlighted the need for better collaboration between the industry and the startups in order to pace up the momentum of innovation in healthcare. The emphasis was on digitization taking a front seat during COVID and how with the help of technology, Indian healthcare has been able to deliver health services in remote parts in the country. The interaction between the industry leaders and the entrepreneurs charted a way forward for Indian health sector to expand the infrastructure and ensure better patient outcome with the help of Artificial Intelligence, IoT, big data analysis, telemedicine and teleconsultation.

Ms. Eshika Arora from NATHEALTH Innovation forum presented a report based on an extensive research undertaken with various healthcare providers highlighting the potential for co-innovation between the industry and the startup ecosystem to address the gaps in healthcare capacity, quality, and access. The other industry leaders who attended and spoke at the webinar include Mr. Amit Mookim, MD at IQVIA South Asia and President, TiE Mumbai; Dr. Om Manchanda, MD at Dr. Lal Path Labs, Ms. Meenakshi Nevatia, MD at Stryker India Pvt Ltd; Mr. Harshad Reddy, Director-Operations, Apollo Proton Cancer Centre; Dr. Vidur Mahajan, AD at Mahajan Imaging Pvt Ltd; Mr. Anurag Saxena, Principal and Head – PPG Business, South Asia at IQVIA, Mr. Naveen Raju, Executive Director, TiE Mumbai and Mr. Siddhartha Bhattacharya, Secretary General – NATHEALTH.

The one-day virtual event brought together top healthcare industry leaders and start-up organizations to reimagine India’s present healthcare scenario to build resilience towards future emergencies and pandemics. This industry-startup interface series has been organized to present opportunities for startup organizations to network and collaborate through industry tie-ups on corporate partnerships. Through technological innovations, this startup interface will pave the way forward for bringing solutions to the existing unmet needs of the healthcare industry in India.

Share

Leave a comment

Leave a Reply

Your email address will not be published. Required fields are marked *

Don't Miss

Air Pollution
Health News

Delhi Chokes Under Toxic Air: Schools Shut, Offices Go Work From Home — How to Stay Safe

New Delhi, 23 December, 2025: Delhi once again finds itself gasping for breath as air pollution levels surge to hazardous levels, pushing authorities...

Colorectal cancer
Latest News

Cervical Cancer Awareness Month 2026: Screening Tips Every Woman Should Know

Cervical cancer is one of the most preventable forms of cancer, yet it remains a leading cause of cancer-related deaths among women globally....

Bird Flu
Latest News

Bird Flu Alert: How to Protect Yourself Without Panicking

Bird flu, also known as avian influenza, is a viral infection primarily affecting birds but capable of infecting humans in rare cases. The...

Latest News

Why Walking 30 Minutes a Day Can Add Years to Your Life

Walking for just 30 minutes a day is one of the simplest yet most effective ways to improve overall health, enhance longevity, and...

Latest News

5 Common Foods That Are Slowly Damaging Your Liver

The liver is one of the most vital organs in the body, responsible for detoxification, metabolizing nutrients, and regulating essential biochemical processes, and...

Section title

Related Articles
Cancer
Latest News

Immunotherapy vs Chemotherapy: Which Cancer Treatment Works Better?

Cancer treatment has evolved rapidly over the past few decades, offering patients...

The Nipah virus is considered one of the deadliest zoonotic infections globally, not because it spreads rapidly like influenza or COVID-19, but because of its extremely high fatality rate, rapid progression, and severe brain involvement. Medical experts warn that once symptoms escalate, the disease can turn fatal within days. According to available data, the case fatality rate of Nipah virus ranges between 50 and 75 per cent, placing it among the most lethal viral infections known to humans. In this explainer, Dr Dip Narayan Mukherjee, Consultant – Microbiology and Infectious Diseases, CK Birla Hospitals, CMRI, sheds light on why the virus is so dangerous and difficult to control. Why Is the Nipah Virus So Deadly? According to Dr Mukherjee, Nipah’s lethality lies in a combination of delayed symptom recognition, aggressive disease progression, and early involvement of the brain. “Nipah virus often begins with very non-specific symptoms, which makes early detection difficult. By the time it is clinically suspected, the virus may have already affected the brain,” he explains. Early Symptoms Often Go Unnoticed One of the biggest challenges in controlling Nipah virus is that its initial symptoms closely resemble common viral illnesses, leading to delays in diagnosis and isolation. Early symptoms include: Fever Headache Cough Muscle pain General weakness “These symptoms are easily mistaken for flu, viral fever, or respiratory infections,” says Dr Mukherjee. “This delay gives the virus time to progress silently.” Severe Brain Infection Drives High Mortality The most dangerous aspect of Nipah virus infection is its neurological involvement. The virus frequently causes encephalitis, or inflammation of the brain, which significantly increases the risk of death. Neurological symptoms may include: Seizures Confusion and altered consciousness Extreme drowsiness Coma “Once the central nervous system is involved, the disease becomes very difficult to manage,” Dr Mukherjee notes. “At this stage, treatment is largely supportive because there is no specific antiviral therapy available.” This lack of targeted treatment options makes early detection critical. Human-to-Human Transmission Raises Risk While Nipah virus is primarily transmitted from fruit bats, it can also spread from person to person, particularly in healthcare settings. Dr Mukherjee points out that: Caregivers and healthcare workers are at higher risk Exposure to high viral loads can worsen outcomes Inadequate infection control increases transmission risk “Strict adherence to infection control practices is essential. Even a small lapse can result in secondary infections,” he says. Zoonotic Nature Makes Exposure Hard to Predict Nipah virus is transmitted from fruit bats, either directly or through intermediate hosts such as pigs. This zoonotic pattern makes outbreaks unpredictable, especially in regions where humans, animals, and wildlife interact closely. Adding to the challenge: There is no approved vaccine Treatment options remain limited Isolation protocols must be strictly enforced What Can Reduce Nipah Fatalities? According to experts, early action remains the most effective defence against Nipah virus. Key measures include: Early isolation of suspected cases Strict use of personal protective equipment (PPE) Rapid escalation and referral to specialised centres Strong hospital infection control protocols “The earlier the virus is identified and contained, the better the chances of preventing severe disease and fatalities,” Dr Mukherjee emphasises. The Bottom Line Nipah virus continues to be a serious public health threat because of its high fatality rate, neurological complications, and lack of targeted treatment. Its ability to masquerade as a mild illness in the early stages makes vigilance crucial. Health experts stress that awareness, early suspicion, and strict infection control are currently the most powerful tools to reduce deaths linked to this deadly virus. As Dr Mukherjee concludes, “With Nipah, time is the most critical factor. Early recognition can save lives.”
Latest News

Why Nipah Virus Has a High Fatality Rate: Factors Affecting Disease Severity

The Nipah virus is widely regarded as one of the deadliest zoonotic...

Latest News

Stroke Risk in India: Symptoms and Urgent Action Steps

Stroke is a leading cause of death and disability in India, yet...

Latest News

Silent Struggle: Over 15 Million Indians Live with Epilepsy, Experts Stress Early Diagnosis and Care

Epilepsy, a neurological disorder that causes recurrent seizures, affects more than 15...

×